{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:29:24Z","timestamp":1787956164944,"version":"build-2784847793"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"DOI":"10.1186\/s12245-025-00876-6","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T18:02:25Z","timestamp":1746986545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Stem cell therapy use in patients with dementia: a systematic review"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-9027","authenticated-orcid":false,"given":"Olivier","family":"Uwishema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0702-0139","authenticated-orcid":false,"given":"Malak","family":"Ghezzawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6903-0206","authenticated-orcid":false,"given":"Magda","family":"Wojtara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8785-8875","authenticated-orcid":false,"given":"Ignatius N","family":"Esene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0265-1953","authenticated-orcid":false,"given":"Kehinde","family":"Obamiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"1","key":"876_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s40001-024-01987-1","volume":"29","author":"R Rahimi Darehbagh","year":"2024","unstructured":"Rahimi Darehbagh R, Seyedoshohadaei SA, Ramezani R, Rezaei N. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives. Eur J Med Res. 2024;29(1):386\u201320.","journal-title":"Eur J Med Res"},{"key":"876_CR2","doi-asserted-by":"crossref","unstructured":"He Z. Research progress and prospects of mesenchymal stem cells for neurodegenerative disease treatment. In: Gao X, editor. Biological sciences and environmental health. 1 ed. CRC; 2025. pp. 37\u201342.","DOI":"10.1201\/9781003587590-6"},{"key":"876_CR3","doi-asserted-by":"publisher","first-page":"102458","DOI":"10.1016\/j.scr.2021.102458","volume":"55","author":"IL Llorente","year":"2021","unstructured":"Llorente IL, Hatanaka EA, Meadow ME, Xie Y, Lowry WE, Carmichael ST. Reliable generation of glial enriched progenitors from human fibroblast-derived iPSCs. Stem Cell Res. 2021;55:102458.","journal-title":"Stem Cell Res"},{"issue":"4","key":"876_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22042153","volume":"22","author":"F Sivandzade","year":"2021","unstructured":"Sivandzade F, Cucullo L. Regenerative stem cell therapy for neurodegenerative diseases: an overview. Int J Mol Sci. 2021;22(4):1\u201321.","journal-title":"Int J Mol Sci"},{"key":"876_CR5","unstructured":"World Health Organization. Dementia 2023 [Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia"},{"issue":"1","key":"876_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0567-5","volume":"8","author":"T Duncan","year":"2017","unstructured":"Duncan T, Valenzuela M. Alzheimer\u2019s disease, dementia, and stem cell therapy. Stem Cell Res Ther. 2017;8(1):1\u20139.","journal-title":"Stem Cell Res Ther"},{"key":"876_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/B978-0-12-818084-6.00004-0","volume-title":"Handbook of innovations in central nervous system regenerative medicine","author":"M Gago","year":"2020","unstructured":"Gago M, Machado A, Rocha S. Current clinical approaches in neurodegenerative diseases. In: Salgado A, editor. Handbook of innovations in central nervous system regenerative medicine. United States: Elsevier; 2020. pp. 79\u2013124."},{"issue":"7","key":"876_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/0113892037275221240327042353","volume":"25","author":"K Singh","year":"2024","unstructured":"Singh K, Gupta JK, Kumar S, Soni U. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of bioactive peptides. Curr Protein Pept Sci. 2024;25(7):507\u201326.","journal-title":"Curr Protein Pept Sci"},{"key":"876_CR9","doi-asserted-by":"crossref","unstructured":"Rezaei S, Morshedi K, Shafabakhsh R, Mahjoubin-Tehran M. Current therapies for neurological disorders and their limitations. Phytonutrients and Neurological Disorders: Therapeutic and Toxicological Aspects2023. pp. 107\u2013\u200930.","DOI":"10.1016\/B978-0-12-824467-8.00009-7"},{"issue":"10","key":"876_CR10","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.3390\/ijms25105169","volume":"25","author":"J Li","year":"2024","unstructured":"Li J, Haj Ebrahimi A, Ali AB. Advances in therapeutics to alleviate cognitive decline and neuropsychiatric symptoms of Alzheimer\u2019s disease. Int J Mol Sci. 2024;25(10):5169.","journal-title":"Int J Mol Sci"},{"key":"876_CR11","doi-asserted-by":"publisher","first-page":"116821","DOI":"10.1016\/j.biopha.2024.116821","volume":"176","author":"M Chvojkova","year":"2024","unstructured":"Chvojkova M, Kolar D, Kovacova K, Cejkova L, Misiachna A, Hakenova K, et al. Pro-cognitive effects of dual Tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists. Biomed Pharmacother. 2024;176:116821.","journal-title":"Biomed Pharmacother"},{"key":"876_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ydbio.2021.06.012","volume":"478","author":"B Guy","year":"2021","unstructured":"Guy B, Zhang JS, Duncan LH, Johnston RJ. Human neural organoids: models for developmental neurobiology and disease. Dev Biol. 2021;478:102\u201321.","journal-title":"Dev Biol"},{"key":"876_CR13","doi-asserted-by":"crossref","unstructured":"Jean KRP, Dotson VMP. Dement Neurologic Clin. 2024;42(4):793\u2013807.","DOI":"10.1016\/j.ncl.2024.05.005"},{"key":"876_CR14","doi-asserted-by":"crossref","unstructured":"Tsering W, Lolo K, Phillips JL, Golde T, Prokop S. Accumulation of novel Amyloidosis-associated proteins in the progression of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2024;20(S1):n\/a-n\/a.","DOI":"10.1002\/alz.092565"},{"key":"876_CR15","first-page":"9","volume-title":"Animal-Assisted intervention and dementia: A systematic review","author":"ML Yakimicki","year":"2019","unstructured":"Yakimicki ML, Edwards NE, Richards E, Beck AM. Animal-Assisted intervention and dementia: A systematic review. Los Angeles, CA: SAGE; 2019. pp. 9\u201329."},{"issue":"4","key":"876_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3233\/JAD-170045","volume":"57","author":"G Esquerda-Canals","year":"2017","unstructured":"Esquerda-Canals G, Montoliu-Gaya L, G\u00fcell-Bosch J, Villegas S. Mouse models of Alzheimer\u2019s disease. J Alzheimers Dis. 2017;57(4):1171\u201383.","journal-title":"J Alzheimers Dis"},{"key":"876_CR17","doi-asserted-by":"crossref","unstructured":"Venkat PCM, Chen J. Models and mechanisms of vascular dementia. Exp Neurol. 2015.","DOI":"10.1016\/j.expneurol.2015.05.006"},{"issue":"4","key":"876_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/ddr.430350403","volume":"35","author":"RD Porsolt","year":"1995","unstructured":"Porsolt RD, Roux S, Wettstein JG. Animal models of dementia. Drug Dev Res. 1995;35(4):214\u201329.","journal-title":"Drug Dev Res"},{"issue":"9","key":"876_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2174\/156720512803569055","volume":"9","author":"A Anand","year":"2012","unstructured":"Anand A, Banik A, Thakur K, Masters CL. The animal models of dementia and Alzheimer\u2019s disease for pre-clinical testing and clinical translation. Curr Alzheimer Res. 2012;9(9):1010\u201329.","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"876_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neulet.2008.12.001","volume":"450","author":"AG Xuan","year":"2009","unstructured":"Xuan AG, Luo M, Ji WD, Long DH. Effects of engrafted neural stem cells in Alzheimer\u2019s disease rats. Neurosci Lett. 2009;450(2):167\u201371.","journal-title":"Neurosci Lett"},{"issue":"5","key":"876_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/jnr.23182","volume":"91","author":"D Park","year":"2013","unstructured":"Park D, Yang G, Bae DK, Lee SH, Yang Y-H, Kyung J, et al. Human adipose tissue-derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice. J Neurosci Res. 2013;91(5):660\u201370.","journal-title":"J Neurosci Res"},{"key":"876_CR22","doi-asserted-by":"crossref","unstructured":"Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. Human Stem\/Progenitor Cells from Bone Marrow Promote Neurogenesis of Endogenous Neural Stem Cells in the Hippocampus of Mice. Proceedings of the National Academy of Sciences - PNAS. 2005;102(50):18171-6.","DOI":"10.1073\/pnas.0508945102"},{"issue":"2","key":"876_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12015-014-9576-2","volume":"11","author":"FG Teixeira","year":"2015","unstructured":"Teixeira FG, Carvalho MM, Neves-Carvalho A, Panchalingam KM, Behie LA, Pinto L, et al. Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural\/glial proliferation and differentiation. Stem Cell Rev. 2015;11(2):288\u201397.","journal-title":"Stem Cell Rev"},{"issue":"6","key":"876_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3727\/096368914X679237","volume":"24","author":"SH Oh","year":"2015","unstructured":"Oh SH, Kim HN, Park HJ, Shin JY, Lee PH. Mesenchymal stem cells increase hippocampal neurogenesis and neuronal differentiation by enhancing the Wnt signaling pathway in an Alzheimer\u2019s disease model. Cell Transplant. 2015;24(6):1097\u2013109.","journal-title":"Cell Transplant"},{"issue":"8","key":"876_CR25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/scd.2010.0466","volume":"20","author":"JC Ra","year":"2011","unstructured":"Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011;20(8):1297\u2013308.","journal-title":"Stem Cells Dev"},{"issue":"7359","key":"876_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10202","volume":"476","author":"ZP Pang","year":"2011","unstructured":"Pang ZP, Yang N, Vierbuchen T, Ostermeier A, Fuentes DR, Yang TQ, et al. Induction of human neuronal cells by defined transcription factors. Nat (London). 2011;476(7359):220\u20133.","journal-title":"Nat (London)"},{"issue":"2","key":"876_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/cr.2011.181","volume":"22","author":"X Liu","year":"2012","unstructured":"Liu X, Li F, Stubblefield EA, Blanchard B, Richards TL, Larson GA, et al. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res. 2012;22(2):321\u201332.","journal-title":"Cell Res"},{"issue":"7","key":"876_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.5966\/sctm.2014-0184","volume":"4","author":"A Eckert","year":"2015","unstructured":"Eckert A, Huang L, Gonzalez R, Kim H-S, Hamblin MH, Lee J-P. Bystander effect fuels human induced pluripotent stem Cell-Derived neural stem cells to quickly attenuate early stage neurological deficits after stroke. Stem Cells Translational Med. 2015;4(7):841\u201351.","journal-title":"Stem Cells Translational Med"},{"key":"876_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neulet.2013.10.043","volume":"557","author":"N Fujiwara","year":"2013","unstructured":"Fujiwara N, Shimizu J, Takai K, Arimitsu N, Saito A, Kono T, et al. Restoration of Spatial memory dysfunction of human APP Transgenic mice by transplantation of neuronal precursors derived from human iPS cells. Neurosci Lett. 2013;557:129\u201334.","journal-title":"Neurosci Lett"},{"issue":"2","key":"876_CR30","first-page":"95","volume":"1","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J, et al. Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: A phase 1 clinical trial. Alzheimer\u2019s Dementia: Translational Res Clin Interventions. 2015;1(2):95\u2013102.","journal-title":"Alzheimer\u2019s Dementia: Translational Res Clin Interventions"},{"issue":"1","key":"876_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","volume":"13","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, et al. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase I clinical trial. Alzheimers Res Ther. 2021;13(1):154.","journal-title":"Alzheimers Res Ther"},{"key":"876_CR32","unstructured":"ClinicalTrials.gov. Alzheimer\u2019s Autism and Cognitive Impairment Stem Cell Treatment Study (ACIST) 2018 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT03724136"},{"key":"876_CR33","unstructured":"ClinicalTrials.gov. The Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer\u2019s Disease 2020 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT04388982"},{"key":"876_CR34","unstructured":"ClinicalTrials.gov. A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer\u2019s Disease 2020 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT04228666"},{"key":"876_CR35","unstructured":"ClinicalTrials.gov. A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer\u2019s Disease 2017 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT03117738"},{"issue":"1","key":"876_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1479-5876-8-131","volume":"8","author":"A Liras","year":"2010","unstructured":"Liras A. Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J Translational Med. 2010;8(1):131.","journal-title":"J Translational Med"},{"issue":"8","key":"876_CR37","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1089\/scd.2009.0482","volume":"19","author":"ML Condic","year":"2010","unstructured":"Condic ML, Rao M. Alternative sources of pluripotent stem cells: ethical and scientific issues revisited. Stem Cells Dev. 2010;19(8):1121\u20139.","journal-title":"Stem Cells Dev"},{"issue":"6","key":"876_CR38","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","volume":"34","author":"X Wei","year":"2013","unstructured":"Wei X, Yang X, Han ZP, Qu FF, Shao L, Shi YF. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34(6):747\u201354.","journal-title":"Acta Pharmacol Sin"},{"key":"876_CR39","volume-title":"Hippocampus","author":"J Kun","year":"2021","unstructured":"Kun J, Yongqi Z, Lei Z. New prospects for stem cell therapy in Alzheimer\u2019s disease. In: Xinhua Z, editor. Hippocampus. Rijeka: IntechOpen; 2021. Ch. 9."},{"issue":"5","key":"876_CR40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s12015-013-9443-6","volume":"9","author":"PL Mart\u00ednez-Morales","year":"2013","unstructured":"Mart\u00ednez-Morales PL, Revilla A, Oca\u00f1a I, Gonz\u00e1lez C, Sainz P, McGuire D, et al. Progress in stem cell therapy for major human neurological disorders. Stem Cell Rev. 2013;9(5):685\u201399.","journal-title":"Stem Cell Rev"},{"key":"876_CR41","unstructured":"ClinicalTrials.gov. Alzheimer\u2019s Disease Stem Cells Multiple Infusions 2019 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT04040348"},{"key":"876_CR42","unstructured":"ClinicalTrials.gov. The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem\u00ae-AD 2012 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT01696591"},{"key":"876_CR43","unstructured":"ClinicalTrials.gov. Neurologic Stem Cell Treatment Study (NEST) 2016 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT02795052"},{"key":"876_CR44","unstructured":"ClinicalTrials.gov. Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer\u2019s Disease [Available from: https:\/\/clinicaltrials.gov\/study\/NCT04855955"},{"key":"876_CR45","unstructured":"ClinicalTrials.gov. Safety and exploratory efficacy study of UCMSCs in patients with Alzheimer\u2019s disease (SEESUPAD) 2021 [Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02672306"},{"key":"876_CR46","unstructured":"ClinicalTrials.gov. Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer\u2019s Disease (SEMAD) 2012 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT01547689"},{"key":"876_CR47","unstructured":"ClinicalTrials.gov, Lomecel. -B Infusion Versus Placebo in Patients With Alzheimer\u2019s Disease 2016 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT02600130"},{"key":"876_CR48","unstructured":"ClinicalTrials.gov. Exploratory Efficacy Study of NEUROSTEM\u00ae in Subjects Who Control Group of NEUROSTEM\u00ae 2021 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT04954534"},{"key":"876_CR49","unstructured":"ClinicalTrials.gov. Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM\u00ae Phase-I\/\u200bIIa Clinical Trial. 2017 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT03172117?cond=NCT03172117%26;rank=1"},{"key":"876_CR50","unstructured":"ClinicalTrials.gov. Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer\u2019s Disease 2016 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT02912169?tab=history%26;a=2"},{"key":"876_CR51","unstructured":"ClinicalTrials.gov. Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer\u2019s Disease 2023 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT04482413"},{"key":"876_CR52","unstructured":"ClinicalTrials.gov. Autologous Stem\/\u200bStromal Cells in Neurological Disorders and Disease (NDD) 2020 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT03297177"},{"key":"876_CR53","unstructured":"ClinicalTrials.gov. Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions 2019 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT03899298?cond=NCT03899298%26;rank=1"},{"key":"876_CR54","unstructured":"ClinicalTrials.gov. Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions 2020 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT04684602"},{"key":"876_CR55","unstructured":"ClinicalTrials.gov. Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer\u2019s Disease 2016 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT02899091"},{"issue":"3","key":"876_CR56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.32604\/biocell.2022.017248","volume":"46","author":"R Zhang","year":"2022","unstructured":"Zhang R, Li C, Du R, Yuan Y, Zhao B, Zhang Y, et al. Mesenchymal stem cells: as a multi-target cell therapy for clearing \u03b2-amyloid deposition in Alzheimer\u2019s disease. Biocell. 2022;46(3):583\u201392.","journal-title":"Biocell"},{"issue":"2016","key":"876_CR57","first-page":"1","volume":"2016","author":"Q Li","year":"2016","unstructured":"Li Q, Guo A-y, Chen Z, Wang H, Gao F, Lei Q, et al. Mesenchymal stem Cell-Derived microvesicles support ex vivo expansion of cord Blood-Derived CD34\u2009+\u2009Cells. Stem Cells Int. 2016;2016(2016):1\u201313.","journal-title":"Stem Cells Int"},{"issue":"3","key":"876_CR58","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3233\/JAD-221253","volume":"93","author":"K Zhang","year":"2023","unstructured":"Zhang K, Du X, Gao Y, Liu S, Xu Y. Mesenchymal stem cells for treating Alzheimer\u2019s disease: cell therapy and chemical reagent pretreatment. J Alzheimers Dis. 2023;93(3):863.","journal-title":"J Alzheimers Dis"},{"key":"876_CR59","doi-asserted-by":"crossref","unstructured":"Ou C-M, Xue W-W, Liu D, Ma L, Xie H-T, Ning K. Stem cell therapy in Alzheimer\u2019s disease: current status and perspectives. Front NeuroSci. 2024;18.","DOI":"10.3389\/fnins.2024.1440334"},{"issue":"10","key":"876_CR60","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2174\/0115680266282492240220101049","volume":"24","author":"P Madar","year":"2024","unstructured":"Madar P, Nagalapur P, Chaudhari S, Sharma D, Koparde A, Buchade R, et al. The unveiling of therapeutic targets for Alzheimer\u2019s disease: an integrative review. Curr Top Med Chem. 2024;24(10):850.","journal-title":"Curr Top Med Chem"},{"key":"876_CR61","doi-asserted-by":"publisher","first-page":"e20240147","DOI":"10.1590\/1980-5764-dn-2024-0147","volume":"18","author":"H Feizi","year":"2024","unstructured":"Feizi H, Hosseini M-S, Seyedi-Sahebari S, Karimi H, Mosaddeghi-Heris R, Sadigh-Eteghad S, et al. A systematic review of clinical efficacy and safety of cell-based therapies in Alzheimer\u2019s disease. Dement Neuropsychologia. 2024;18:e20240147.","journal-title":"Dement Neuropsychologia"},{"issue":"22","key":"876_CR62","doi-asserted-by":"publisher","first-page":"12378","DOI":"10.3390\/ijms252212378","volume":"25","author":"E Belousova","year":"2024","unstructured":"Belousova E, Salikhova D, Maksimov Y, Nebogatikov V, Sudina A, Goldshtein D, et al. Proposed mechanisms of cell therapy for Alzheimer\u2019s disease. Int J Mol Sci. 2024;25(22):12378.","journal-title":"Int J Mol Sci"},{"key":"876_CR63","doi-asserted-by":"crossref","unstructured":"Lee G, Glicksman M, Patel R, Vanjani N, Kumthekar P, DDEL-10. retrospective review of intra-csf drug, delivery: safety and drug distribution profiles of intracerebroventricular (ICV). Lumbar intrathecal (LIT), and intra-cisterna magna (ICM) Injections. Neuro-oncology. (Charlottesville Va). 2023;25(Supplement5):v103\u2013v.","DOI":"10.1093\/neuonc\/noad179.0389"},{"issue":"6","key":"876_CR64","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1586\/14760584.3.6.717","volume":"3","author":"NB Chauhan","year":"2004","unstructured":"Chauhan NB, Siegel GJ. Intracerebroventricular passive immunization in Transgenic mouse models of Alzheimer\u2019s disease. Expert Rev Vaccines. 2004;3(6):717\u201325.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"876_CR65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10561-017-9609-6","volume":"18","author":"Y He","year":"2017","unstructured":"He Y, Jin X, Wang J, Meng M, Hou Z, Tian W, et al. Umbilical cord-derived mesenchymal stem cell transplantation for treating elderly vascular dementia. Cell Tissue Banking. 2017;18(1):53\u20139.","journal-title":"Cell Tissue Banking"},{"key":"876_CR66","doi-asserted-by":"crossref","unstructured":"Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, M\u00fcller F-J, Loring JF et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proceedings of the National Academy of Sciences - PNAS. 2009;106(32):13594-9.","DOI":"10.1073\/pnas.0901402106"},{"issue":"1\u20132","key":"876_CR67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2152\/jmi.53.61","volume":"53","author":"Q Wang","year":"2006","unstructured":"Wang Q, Matsumoto Y, Shindo T, Miyake K, Shindo A, Kawanishi M, et al. Neural stem cells transplantation in cortex in a mouse model of Alzheimer\u2019s disease. J Med Invest. 2006;53(1\u20132):61.","journal-title":"J Med Invest"},{"key":"876_CR68","doi-asserted-by":"publisher","first-page":"1011225","DOI":"10.3389\/fnmol.2022.1011225","volume":"15","author":"S Regmi","year":"2022","unstructured":"Regmi S, Liu DD, Shen M, Kevadiya BD, Ganguly A, Primavera R, et al. Mesenchymal stromal cells for the treatment of Alzheimer\u2019s disease: strategies and limitations. Front Mol Neurosci. 2022;15:1011225.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"876_CR69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/alz.12651","volume":"19","author":"M Brody","year":"2023","unstructured":"Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, et al. Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2023;19(1):261\u201373.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"S9","key":"876_CR70","doi-asserted-by":"publisher","first-page":"na","DOI":"10.1002\/alz.057581","volume":"17","author":"AA Oliva","year":"2021","unstructured":"Oliva AA, Brody M, Agronin M, Herskowitz B, Bookheimer SY, Hitchinson B, et al. Safety and efficacy of Lomecel-B in patients with mild Alzheimer\u2019s disease: results of a double\u2010blinded, randomized, placebo\u2010controlled phase 1 clinical trial. Alzheimer\u2019s Dement. 2021;17(S9):na\u2013na.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"876_CR71","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer\u2019s Dement. 2013;9(1):63\u2013e752.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"876_CR72","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/1673-5374.265544","volume":"15","author":"F-Q Zhang","year":"2020","unstructured":"Zhang F-Q, Jiang J-L, Zhang J-T, Niu H, Fu X-Q, Zeng L-L. Current status and future prospects of stem cell therapy in Alzheimer\u2019s disease. Neural Regeneration Res. 2020;15(2):242\u201350.","journal-title":"Neural Regeneration Res"},{"issue":"7","key":"876_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.21037\/sci.2017.07.03","volume":"4","author":"F Cl\u00e9ment","year":"2017","unstructured":"Cl\u00e9ment F, Grockowiak E, Zylbersztejn F, Fossard G, Gobert S, Maguer-Satta V. Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence. Stem Cell Invest. 2017;4(7):67.","journal-title":"Stem Cell Invest"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-025-00876-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-025-00876-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-025-00876-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T18:02:37Z","timestamp":1746986557000},"score":1,"resource":{"primary":{"URL":"https:\/\/intjem.biomedcentral.com\/articles\/10.1186\/s12245-025-00876-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1186\/s12245-025-00876-6","relation":{},"ISSN":["1865-1380"],"issn-type":[{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":".","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registration on Prospero"}}],"article-number":"95"}}